NasdaqGS - Delayed Quote USD

Clover Health Investments, Corp. (CLOV)

Compare
4.3300 +0.1300 (+3.10%)
At close: 4:00 PM EST
4.3299 -0.00 (-0.00%)
After hours: 4:08 PM EST
Loading Chart for CLOV
DELL
  • Previous Close 4.2000
  • Open 4.2000
  • Bid 4.3100 x 2100
  • Ask 4.3600 x 4000
  • Day's Range 4.0800 - 4.3900
  • 52 Week Range 0.6060 - 4.7100
  • Volume 6,400,014
  • Avg. Volume 9,335,684
  • Market Cap (intraday) 2.154B
  • Beta (5Y Monthly) 2.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2400
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.74

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

www.cloverhealth.com/en/

552

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CLOV

View More

Performance Overview: CLOV

Trailing total returns as of 11/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CLOV
354.83%
S&P 500
19.77%

1-Year Return

CLOV
297.25%
S&P 500
31.07%

3-Year Return

CLOV
44.63%
S&P 500
22.57%

5-Year Return

CLOV
57.00%
S&P 500
87.84%

Compare To: CLOV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CLOV

View More

Valuation Measures

Annual
As of 11/1/2024
  • Market Cap

    2.09B

  • Enterprise Value

    1.71B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.97

  • Price/Book (mrq)

    6.43

  • Enterprise Value/Revenue

    0.82

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -5.92%

  • Return on Assets (ttm)

    -6.50%

  • Return on Equity (ttm)

    -36.85%

  • Revenue (ttm)

    2.09B

  • Net Income Avi to Common (ttm)

    -120.77M

  • Diluted EPS (ttm)

    -0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    379.05M

  • Total Debt/Equity (mrq)

    1.23%

  • Levered Free Cash Flow (ttm)

    2.19M

Research Analysis: CLOV

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 356.26M
Earnings 7.41M
Q3'23
Q4'23
Q1'24
Q2'24
0
200M
400M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.75 Low
2.74 Average
4.3300 Current
4.00
 

Company Insights: CLOV

People Also Watch